The present invention is directed to a compound falling under Structural Formula (A):
or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.
申请公布号
HRP20151368(T1)
申请公布日期
2016.01.15
申请号
HR2015P001368T
申请日期
2015.12.11
申请人
TETRAPHASE PHARMACEUTICALS, INC.
发明人
ZAHLER, ROBERT B.;CLARK, ROGER B.;HUNT, DIANA KATHARINE;PLAMONDON, LOUIS;XIAO, XIAO-YI;ZHOU, JINGYE
